Local Institution - 102 — Seattle, Washington

Local Institution - 102 is a clinical research site located in Seattle, Washington, United States 98124.

Crixeo Clinical Trials Trust Score: 10/100 (FAILING). This profile has not yet been claimed by the site owner.

Local Institution - 102 has participated in 4 clinical trials with 1 currently active.

Therapeutic areas: Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, Myeloid, Acute.

Sponsors: Celgene, Juno Therapeutics, Inc., a Bristol-Myers Squibb Company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Seattle

Browse all research sites in Washington · View every site in Seattle

Sponsor Feasibility Report

Trust Score: 10/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Local Institution - 102?

Local Institution - 102 has a Crixeo Trust Score of 10/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Local Institution - 102 conducted?

Local Institution - 102 has 4 clinical trials on record, with 1 currently active. Their work covers Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, Myeloid, Acute.

Is Local Institution - 102 accredited by Crixeo Clinical Trials?

Local Institution - 102 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Local Institution - 102?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.